Cargando…
How COVID-19 disrupts glycometabolic control
Autor principal: | Starling, Shimona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202046/ https://www.ncbi.nlm.nih.gov/pubmed/34127837 http://dx.doi.org/10.1038/s41574-021-00526-w |
Ejemplares similares
-
Highlights from SfE BES 2021
por: Starling, Shimona
Publicado: (2021) -
Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021) -
Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020) -
T cells at work: How post‐transcriptional mechanisms control T cell homeostasis and activation
por: Jurgens, Anouk P., et al.
Publicado: (2021) -
Treatment of COVID-19 with MSCs: how does it work?
por: Keating, Armand
Publicado: (2021)